Garuda Therapeutics

BiotechnologySeries ACambridge, USgarudatx.com

Latest round

Series A

Last raised

Oct 2024

Total raised

$158M

Investors

11

About Garuda Therapeutics

Established in 2021 and based in Massachusetts, US, Garuda Therapeutics, Inc. operates as a biopharmaceutical company that creates hematopoietic stem cell therapies. The company was cofounded by Dr. Dhvanit Shah, Dr. David Scadden, and Dr. Sean Morrison. In March 2025, Garuda Therapeutics, Inc. Garuda is developing a hematopoietic stem cell platform that has the potential to cure more than 70 diseases and eliminate dependency on donor or patient cells. The company's platform technology for generating self-renewing blood stem cells is poised to provide patients with broad access to HLA-compatible transgene-free blood stem cell therapies.

Who invested in Garuda Therapeutics

11 investors across 3 rounds

See all investors in Garuda Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Oct 17, 2024

    Amount

    $48M

    Investors

    Locked

  2. Series B

    Jan 23, 2023

    Amount

    $62M

    Investors

    Locked

  3. Series A

    Sep 9, 2021

    Amount

    $48M

    Investors

    Locked

Questions about Garuda Therapeutics

Who invested in Garuda Therapeutics?

Garuda Therapeutics has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Garuda Therapeutics raised?

Garuda Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Garuda Therapeutics last raise money?

Garuda Therapeutics's most recent round on record is a Series A, in Oct 2024.

What does Garuda Therapeutics do?

Established in 2021 and based in Massachusetts, US, Garuda Therapeutics, Inc.

Where is Garuda Therapeutics headquartered?

Garuda Therapeutics is headquartered in Cambridge, US.

Which VCs invest in companies like Garuda Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Garuda Therapeutics's stage. Their profiles are linked below.

Raising like Garuda Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.